Get started

MRK

$MRK UndervaluedHigh Quality and Undervalued NYSE:MRK These eight indicators are all Bullish. If you owned NYSE:MRK for the last 5 years, then you have doubled your investment. There is no guarantee of the future but it looks like the near future target price is $121 Earnings Date: 27th April 2023 On-balance volume (OBV): Bullish Accumulation/distribution line: Bullish Average directional index (ADX): Bullish Aroon oscillator: Bullish Moving average convergence divergence (MACD): Bullish Relative strength index (RSI): Bullish Stochastic oscillator: Bullish Trend based on moving average crossover strategy: Bullish
NYSE:MRK
by VIN786
4/5 Watchlist + NotesInitial Notes - Personally did not trade today, Analysis was on point, rest of week should be exciting SPY - So it looks like scenario 3 that I mentioned on my list last night played out today. We saw both targets to the upside and downside get hit. Premarket we were about 15 cents off of the upside target before opening and pushing higher than yesterdays high. We then saw a sell off during the day to hit our downside target and also create a bearish engulfing, which was scenario 3 mentioned yesterday. I did not get to trade today due to being extremely busy with my personal life, but I was still very happy to see that my analysis was on point, making us 2/2 on the week for predictions. (FOR TOMORROW) Tomorrow I am looking for downside, plain and simple. With the bearish engulfing now created, overextension/exhaustion starting to kick in, and potential for us to create a failed 2U on the weekly chart all tells me that we have some decently bearish catalysts for tomorrow's session. I do not have a specific target for tomorrow to the downside, but if you look at the chart attached to this watchlist, you can see that we formed a broadening expansion on the daily. I am hoping to get close to, test, or surpass the bottom trend line. We must keep in mind that although these engulfing setups typically play out well (The last 7 on SPY's daily have resulted in correct movement in the engulfing candles direction or inside days following), it does not guarantee that we follow suit and see downside. We are still not confirmed reversing yet on longer time frames, but today could very well be the beginning, or sign that we are close to reversing. OVERALL: I want to see us head further down. My rough estimate/target to the downside is 406.43. IF we are lucky then we could see as low as 404. Watchlist + Bias MRK 2-1 Daily: Neutral CRM 2-1 Daily: Bearish MRNA 2-1 Daily: Neutral UNH 2-1 Daily: Slightly Bearish DOCU - 1-3 Daily and 2-1-1 Weekly: BEARISH SQ - 3-1 Weekly: Neutral Previous and Tomorrows Main Watch: DOCU + SHOP SHOP - Neutral on this one. It played out the way we wanted too, but did not hit the target we expected, and was choppy all day. Overall I count this as a win because it followed our criteria and played out as expected, but was hard to catch an entry on if anyone did/tried to, and did not move as much as I had hoped for. DOCU - We STILL have not broken out of the weekly inside setup. Today ended the same as SPY. Bearish Engulfing, with SPY looking like it could reverse any day now, I have to be bearish on DOCU as well. As far as winner/loser status goes for today, I respectfully think this one was an L. It opened under long entry and pushed up slightly above that entry during the first 10 mins of market open before being shot down along with SPY. I personally did not take this trade, but I can see why it may have been a losing trade. For tomorrow, I think a test of the weekly short entry is inevitable, and I will be watching closely to get in some 1-2 week out puts, as well as some close expiry contracts for a day trade. Weekly short trigger is at 56.01. Targets set at 55.24 and 54.86 Watchlist Stats: 2/2 SPY Predictions 2/3 Main Watch Plays Top Winner: SQ 23%+ Personal Stats: 0/1 on the week Overall Red - Did not trade today so stats remain the same. Lets make some money tomorrow! Good Luck all!
AMEX:SPYShort
by Alanger17
(MRK) - Price Targets & Stop Loss 📈 What’s up investors! 📉 Welcome back to another one of 💡“Mike’s Ideas”.💡 I post as I find signals… these signals are based on the personal rules I have built and follow in order to make up what I call the “SST Strategy”. Follow for more ideas in the future!! I have 4 levels marked and colour coded on the Chart. These levels are: 🔴 Red = Stop Loss 🟢 Green = 1.2:1 Risk Reward Ratio 🟡 Yellow = 1.5:1 Risk Reward Ratio 🔵 Blue = 2:1 Risk Reward Ratio 👀 So what are we looking at today…!!! 🚨(MRK) Merck & Co., Inc.🚨 Operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
NYSE:MRKLong
by sststrategy
MRK | Time for Puts | MerckMerck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
NYSE:MRKShort
by DivergenceSeeker
1
Merck has Potential. MRKDivergent on the downside across multiple timeframes. Betting on a triangle B formation, now due for a C Wave to the upside. No confirmation yet. Speculating that this might be a very short term event. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:MRKLong
by Rykin_Capital
Merck & Company Analyze💊!!!Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. The company does business as Merck Sharp & Dohme outside the United States and Canada. Merck was able to break the support lines. For now, it completed its pullback to support lines. I expect that Merck will go down at least to the lower line of descending channel. Merck & Company Analyze ( MRKUSD) Timeframe 4H⏰. Do not forget to put Stop loss for your positions (For every position you want to open). Please follow your strategy, this is just my idea, and I will be glad to see your ideas in this post. Please do not forget the ✅' like '✅ button 🙏😊 & Share it with your friends; thanks, and Trade safe.
NYSE:MRKShort
by pejman_zwin
4
Merck and Company slowing down? Merck and Company Short Term We look to Sell at 93.34 (stop at 96.33) We look to sell rallies. Price action looks to be forming a top. Although the bulls are in control, the stalling positive momentum indicates a turnaround is possible. There is scope for mild buying at the open but gains should be limited. Our profit targets will be 86.55 and 83.96 Resistance: 92.00 / 95.00 / 100.00 Support: 86.50 / 83.50 / 80.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NYSE:MRKShort
by Saxo
Merck heading down as well. MRKOne more huge pharma firm that is biting the dust. A giant flat with a C wave confirmed. No way but down on this one. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:MRKShort
by Rykin_Capital
Merck gaining momentum. MRKImmediate targets 85, 86. Invalidation at 76. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
NYSE:MRKLong
by Rykin_Capital
Merck and Co. gearing for a boost. MRKAnd that's expected to an extent after a sizeable and quick drop. Merck did one, and fractally we are due to a rise that can potentially be viable percentage wise. But who knows what will happen. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
NYSE:MRKLong
by Rykin_Capital
20 years is a long wait, will Merck regain its glorious days ?Study this article carefully ! From a consumer perspective, if these pills are proven safe and effective with minimal side effects, I am sure the take up rate would be much higher , better still if they can be sold at pharmacies and other distribution outlets for easy access. Jabs take a longer time and the process is much longer as it requires the administration by a qualified staff from the healthcare sector. This takes time on both ends and delay the rates of vaccination to some extent. Let's wait patiently and see which stock shows a more bullish signs in the coming weeks.
NYSE:MRK
by dchua1969
$MRK Breaking out of two year accumulation zone into new ATH's.Merck is looking primed for a run into the $90's or higher after breaking 2 years of accumulation on the weekly chart. Ideally I want to see this hold the $84 support level and then bounce back through the all time high's. There is also huge call flow the past two days. One option chain that is getting some attention is Nov 19 $90 calls. Morgan Stanley also raised guidance from $88 to $90 and maintained equal-weight on the stock. Bullish.
NYSE:MRKLong
by CharlestonTrader
1